Acute pancreatitis with uninfected necrosis, unspecified
ICD-10 K85.91 is a billable code used to indicate a diagnosis of acute pancreatitis with uninfected necrosis, unspecified.
Acute pancreatitis with uninfected necrosis, unspecified, is a severe condition characterized by the inflammation of the pancreas, leading to the death of pancreatic tissue (necrosis) without the presence of infection. Clinically, patients may present with severe abdominal pain, nausea, vomiting, and elevated serum amylase and lipase levels. The pancreas, located behind the stomach, plays a crucial role in digestion and blood sugar regulation. In acute pancreatitis, the digestive enzymes become activated prematurely, leading to autodigestion of pancreatic tissue. Disease progression can vary; while some patients may recover fully, others may develop complications such as infected necrosis, abscess formation, or systemic inflammatory response syndrome (SIRS). Diagnostic considerations include imaging studies such as CT scans or MRIs to assess the extent of necrosis and rule out complications. Early identification and management are critical to prevent further morbidity and mortality.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K85.91 specifically covers cases of acute pancreatitis where there is necrosis of pancreatic tissue without infection. It is important to differentiate it from other forms of pancreatitis, such as those with infected necrosis or chronic pancreatitis.
K85.91 should be used when the patient has acute pancreatitis with uninfected necrosis, as indicated by imaging studies and clinical evaluation. It is essential to use this code when there is clear documentation of necrosis without infection.
Documentation should include clinical findings, imaging results (such as CT or MRI), laboratory test results indicating elevated pancreatic enzymes, and a clear statement of the diagnosis by the healthcare provider.